[1]TetrahedronAsymmetry,2006,vol.17,#2,p.245-251
[1]Hoppe-Seyler'sZeitschriftfuerPhysiologischeChemie,1915,vol.94,p.5
[1]Hoppe-Seyler'sZeitschriftfurPhysiologischeChemie,1915,vol.94,p.5
[1]TetrahedronAsymmetry,2006,vol.17,p.245-251
[2]JournalofPharmaceuticalSciences,1996,vol.85,p.1049-1052
[1]ChemischeBerichte,1914,vol.47,p.2632 Hoppe-Seyler'sZeitschriftfuerPhysiologischeChemie,1915,vol.94,p.5
Title: Insights into myalgic encephalomyelitis/chronic fatigue syndrome phenotypes through comprehensive metabolomics.
Journal: Scientific reports 20180101
Title: Urinary phenylacetylglutamine as dosing biomarker for patients with urea cycle disorders.
Journal: Molecular genetics and metabolism 20121101
Title: Ornithine phenylacetate prevents disturbances of motor-evoked potentials induced by intestinal blood in rats with portacaval anastomosis.
Journal: Journal of hepatology 20120101
Title: Structured approach to treat patients with acute liver failure: A hepatic emergency.
Journal: Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine 20120101
Title: Effect of dietary nitrogen content on the urine metabolite profile of dairy cows assessed by nuclear magnetic resonance (NMR)-based metabolomics.
Journal: Journal of agricultural and food chemistry 20111214
Title: Identification of metabolites in the normal ovary and their transformation in primary and metastatic ovarian cancer.
Journal: PloS one 20110101
Title: Management of hepatic encephalopathy.
Journal: International journal of hepatology 20110101
Title: Metabolome-wide association study identifies multiple biomarkers that discriminate north and south Chinese populations at differing risks of cardiovascular disease: INTERMAP study.
Journal: Journal of proteome research 20101203
Title: An unfolded protein response is the initial cellular response to the expression of mutant matrilin-3 in a mouse model of multiple epiphyseal dysplasia.
Journal: Cell stress & chaperones 20101101
Title: Phase 2 comparison of a novel ammonia scavenging agent with sodium phenylbutyrate in patients with urea cycle disorders: safety, pharmacokinetics and ammonia control.
Journal: Molecular genetics and metabolism 20100701
Title: Pharmacology and safety of glycerol phenylbutyrate in healthy adults and adults with cirrhosis.
Journal: Hepatology (Baltimore, Md.) 20100601
Title: From interstitial cystitis to chronic pelvic pain.
Journal: Journal of medicine and life 20100515
Title: Contribution of proteolytic and metabolic sources to hepatic glutamine by (2)H NMR analysis of urinary phenylacetylglutamine (2)H-enrichment from (2)H(2)O.
Journal: Metabolic engineering 20100101
Title: New insights in nutritional management and amino acid supplementation in urea cycle disorders.
Journal: Molecular genetics and metabolism 20100101
Title: A metabonomic approach identifies human urinary phenylacetylglutamine as a novel marker of interstitial cystitis.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20091115
Title: L-ornithine and phenylacetate synergistically produce sustained reduction in ammonia and brain water in cirrhotic rats.
Journal: Hepatology (Baltimore, Md.) 20090701
Title: L-ornithine phenylacetate attenuates increased arterial and extracellular brain ammonia and prevents intracranial hypertension in pigs with acute liver failure.
Journal: Hepatology (Baltimore, Md.) 20090701
Title: Acute fatal presentation of ornithine transcarbamylase deficiency in a previously healthy male.
Journal: Hepatology international 20080901
Title: Epigenetic treatment of myelodysplastic syndromes and acute myeloid leukemias.
Journal: Current medicinal chemistry 20080601
Title: Phase I dose escalation clinical trial of phenylbutyrate sodium administered twice daily to patients with advanced solid tumors.
Journal: Investigational new drugs 20070401
Title: Arginase induction by sodium phenylbutyrate in mouse tissues and human cell lines.
Journal: Molecular genetics and metabolism 20070101
Title: L-Ornithine phenylacetate (OP): a novel treatment for hyperammonemia and hepatic encephalopathy.
Journal: Medical hypotheses 20070101
Title: Does acute glutamine depletion enhance the response of glutamine synthesis to fasting in muscle in adult and old rats?
Journal: Clinical nutrition (Edinburgh, Scotland) 20050601
Title: Aging: gene silencing or gene activation?
Journal: Medical hypotheses 20050101
Title: Pharmacokinetics of sodium phenylacetate and sodium benzoate following intravenous administration as both a bolus and continuous infusion to healthy adult volunteers.
Journal: Molecular genetics and metabolism 20040401
Title: Pharmacokinetics of phenylacetate administered as a 30-min infusion in children with refractory cancer.
Journal: Cancer chemotherapy and pharmacology 20031101
Title: A study of a different dose-intense infusion schedule of phenylacetate in patients with recurrent primary brain tumors consortium report.
Journal: Investigational new drugs 20031101
Title: Low water-soluble uremic toxins.
Journal: Advances in renal replacement therapy 20031001
Title: Integration of [U-13C]glucose and 2H2O for quantification of hepatic glucose production and gluconeogenesis.
Journal: NMR in biomedicine 20030601
Title: The preventive effect of antineoplaston AS2-1 on HCC recurrence.
Journal: Oncology reports 20030101
Title: Glutamine transport in isolated epithelial intestinal cells. Identification of a Na+-dependent transport mechanism, highly specific for glutamine.
Journal: Pflugers Archiv : European journal of physiology 20021201
Title: Identification of phenylbutyrylglutamine, a new metabolite of phenylbutyrate metabolism in humans.
Journal: Journal of mass spectrometry : JMS 20020601
Title: An integrated (2)H and (13)C NMR study of gluconeogenesis and TCA cycle flux in humans.
Journal: American journal of physiology. Endocrinology and metabolism 20011001
Title: A Phase I clinical and pharmacological evaluation of sodium phenylbutyrate on an 120-h infusion schedule.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20011001
Title: A phase I dose escalation and bioavailability study of oral sodium phenylbutyrate in patients with refractory solid tumor malignancies.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20010801
Title: Poesen R, et al. Microbiota-Derived Phenylacetylglutamine Associates with Overall Mortality and Cardiovascular Disease in Patients with CKD. J Am Soc Nephrol. 2016 Nov;27(11):3479-3487.
